Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience.

Autor: Jitaru C; Department of Haematology/Medfuture Research Centre for Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.; Department of Haematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania., Symeonidis A; Haematology Division, Department of Internal Medicine, University of Patras, Patras, Greece., Badelita S; Department of Haematology, Fundeni Clinical Institute, Bucharest, Romania., Katodritou E; Department of Haematology, Theagenion Cancer Hospital, Thessaloniki, Greece., Colita A; Department of Haematology, Coltea Hospital, Bucharest, Romania., Mpanti A; Department of Haematology, Theagenion Cancer Hospital, Thessaloniki, Greece., Bancos A; Department of Haematology/Medfuture Research Centre for Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.; Department of Haematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania., Tigu B; Department of Haematology/Medfuture Research Centre for Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania., Rotariu P; Department of Haematology/Medfuture Research Centre for Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.; Department of Haematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania., Urian L; Department of Haematology/Medfuture Research Centre for Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.; Department of Haematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania., Rus I; Department of Haematology/Medfuture Research Centre for Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.; Department of Haematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania., Dima D; Department of Haematology/Medfuture Research Centre for Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.; Department of Haematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania., Bojan A; Department of Haematology/Medfuture Research Centre for Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.; Department of Haematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania., Damian M; Department of Haematology/Medfuture Research Centre for Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.; Department of Haematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania., Labropoulou V; Department of Internal Medicine, Division of Haematology, University of Patras Medical School, Patras, Greece., Muresan MS; Department of Surgery, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania., Fotiou D; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece., Fetica B; Department of Haematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania., Petrushev B; Department of Pathology, Regional Institute of Gastroenterology and Hepatology, Cluj Napoca, Romania., Dascalescu A; Department of Hematology, Regional Institute of Oncology, Iasi, Romania., Dalampira D; Department of Haematology, Theagenion Cancer Hospital, Thessaloniki, Greece., Buruiana S; Department of Hematology, Nicolae Testemitanu University of Medicine and Pharmacy, Chisinau, Moldova., Constantinescu C; Department of Haematology/Medfuture Research Centre for Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania., Zdrenghea M; Department of Haematology/Medfuture Research Centre for Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.; Department of Haematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece., Tomuleasa C; Department of Haematology/Medfuture Research Centre for Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.; Department of Haematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania., Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece.

Publikováno v: Journal of hematology [J Hematol] 2024 Oct; Vol. 13 (5), pp. 207-215. Date of Electronic Publication: 2024 Oct 21.